{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T13:11:25Z","timestamp":1782738685549,"version":"3.54.5"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T00:00:00Z","timestamp":1656460800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T00:00:00Z","timestamp":1656460800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Surg"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>In this study, we aimed at elucidating the postoperative survival and prognostic factors in patients with biliary neuroendocrine neoplasm (NEN).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Cases of biliary system NEN and adenocarcinoma from 1975 to 2016 were extracted from the Surveillance, Epidemiology, and End Results (SEER) database. A propensity score matching (PSM) method was used to adjust baseline differences in clinicopathological characteristics in our analysis. The Kaplan\u2013Meier analysis was carried out for survival analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 233 patients with biliary system NEN were enrolled in this study, of which 119 patients\u2019 lesions located in gallbladder, while the others\u2019 located in bile duct. The postoperative overall survival of bile duct NEN is significantly longer than that of gallbladder NEN (P\u2009&lt;\u20090.001). For gallbladder NENs, surgery method (P\u2009=\u20090.020) and lymph node metastasis (P\u2009=\u20090.018) were identified as independent prognostic factors. In terms of ampulla of vater (AOV) NENs, age (P\u2009=\u20090.017) and lymph node metastasis (P\u2009=\u20090.006) were identified as independent prognostic factors, while grade (P\u2009=\u20090.002) and lymph node metastasis (P\u2009=\u20090.036) were identified as independent prognostic factors for extrahepatic bile duct (EBD) NENs. PSM analysis indicated that patients with biliary duct NENs have a better postoperative prognosis than biliary duct adenocarcinoma.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Patients with NEN have better overall survival than patients with adenocarcinoma. Gallbladder NEN has an adverse prognosis than that of biliary tract NEN. The pathological subtype, differentiation, lymph node metastasis, surgery method, and lymph node resection could affect the postoperative prognosis of the gallbladder and biliary tract NEN.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12893-022-01689-7","type":"journal-article","created":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T13:04:58Z","timestamp":1656507898000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The clinical and prognostic factors for biliary neuroendocrine neoplasm: a study based on the SEER database"],"prefix":"10.1186","volume":"22","author":[{"given":"Bo-Hao","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Ze","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Tao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Jian","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Ling","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Suo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hou-Bao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,29]]},"reference":[{"issue":"4","key":"1689_CR1","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1002\/cncr.11105","volume":"97","author":"IM Modlin","year":"2003","unstructured":"Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer. 2003;97(4):934\u201359.","journal-title":"Cancer"},{"issue":"4","key":"1689_CR2","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1002\/ijc.23529","volume":"123","author":"MM Hassan","year":"2008","unstructured":"Hassan MM, et al. Risk factors associated with neuroendocrine tumors: a U.S.-based case\u2013control study. Int J Cancer. 2008;123(4):867\u201373.","journal-title":"Int J Cancer"},{"issue":"1","key":"1689_CR3","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.hoc.2015.08.006","volume":"30","author":"AI Vinik","year":"2016","unstructured":"Vinik AI, Chaya C. Clinical presentation and diagnosis of neuroendocrine tumors. Hematol Oncol Clin North Am. 2016;30(1):21\u201348.","journal-title":"Hematol Oncol Clin North Am"},{"issue":"1","key":"1689_CR4","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1001\/jamaoncol.2019.4568","volume":"6","author":"A Chauhan","year":"2020","unstructured":"Chauhan A, Kohn E, Del Rivero J. Neuroendocrine tumors-less well known, often misunderstood, and rapidly growing in incidence. JAMA Oncol. 2020;6(1):21\u20132.","journal-title":"JAMA Oncol"},{"issue":"12","key":"1689_CR5","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.neo.2017.09.002","volume":"19","author":"B Oronsky","year":"2017","unstructured":"Oronsky B, et al. Nothing but NET: a review of neuroendocrine tumors and carcinomas. Neoplasia. 2017;19(12):991\u20131002.","journal-title":"Neoplasia"},{"issue":"4","key":"1689_CR6","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s40618-021-01715-0","volume":"45","author":"T Feola","year":"2022","unstructured":"Feola T, et al. Risk factors for gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a three-centric case-control study. J Endocrinol Investig. 2022;45(4):849\u201357.","journal-title":"J Endocrinol Investig"},{"key":"1689_CR7","volume-title":"WHO classification of tumours","author":"FT Bosman","year":"2010","unstructured":"Bosman FT, Carneiro F, Hruban RH, Theise ND. WHO classification of tumours of the digestive system. In: WHO classification of tumours, vol. 3. 4th ed. Lyon: IARC Press; 2010.","edition":"4"},{"issue":"2","key":"1689_CR8","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/his.13975","volume":"76","author":"ID Nagtegaal","year":"2020","unstructured":"Nagtegaal ID, et al. The 2019 WHO classification of tumours of the digestive system. Histopathology. 2020;76(2):182\u20138.","journal-title":"Histopathology"},{"issue":"4","key":"1689_CR9","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1002\/(SICI)1097-0142(19970215)79:4<813::AID-CNCR19>3.0.CO;2-2","volume":"79","author":"IM Modlin","year":"1997","unstructured":"Modlin IM, Sandor A. An analysis of 8305 cases of carcinoid tumors. Cancer. 1997;79(4):813\u201329.","journal-title":"Cancer"},{"issue":"6","key":"1689_CR10","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.anndiagpath.2009.08.002","volume":"13","author":"J Albores-Saavedra","year":"2009","unstructured":"Albores-Saavedra J, et al. Carcinoid tumors and small-cell carcinomas of the gallbladder and extrahepatic bile ducts: a comparative study based on 221 cases from the Surveillance, Epidemiology, and End Results Program. Ann Diagn Pathol. 2009;13(6):378\u201383.","journal-title":"Ann Diagn Pathol"},{"issue":"10","key":"1689_CR11","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1097\/MCG.0b013e3181d7a6d4","volume":"44","author":"KM Eltawil","year":"2010","unstructured":"Eltawil KM, et al. Neuroendocrine tumors of the gallbladder: an evaluation and reassessment of management strategy. J Clin Gastroenterol. 2010;44(10):687\u201395.","journal-title":"J Clin Gastroenterol"},{"issue":"4","key":"1689_CR12","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s12253-014-9808-4","volume":"20","author":"N Michalopoulos","year":"2014","unstructured":"Michalopoulos N, et al. Neuroendocrine tumors of extrahepatic biliary tract. Pathol Oncol Res. 2014;20(4):765\u201375.","journal-title":"Pathol Oncol Res"},{"issue":"29","key":"1689_CR13","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000011487","volume":"97","author":"L Zhang","year":"2018","unstructured":"Zhang L, et al. Neuroendocrine carcinoma in the extrahepatic biliary tract: a case report and literature review. Medicine (Baltimore). 2018;97(29): e11487.","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"1689_CR14","doi-asserted-by":"publisher","first-page":"e463","DOI":"10.1016\/j.clgc.2016.10.007","volume":"15","author":"O Abdel-Rahman","year":"2017","unstructured":"Abdel-Rahman O. Squamous cell carcinoma of the bladder: a SEER database analysis. Clin Genitourin Cancer. 2017;15(3):e463\u20138.","journal-title":"Clin Genitourin Cancer"},{"key":"1689_CR15","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.lungcan.2018.11.010","volume":"126","author":"BD Qin","year":"2018","unstructured":"Qin BD, et al. Clinical, pathological and treatment factors associated with the survival of patients with primary pulmonary salivary gland-type tumors. Lung Cancer. 2018;126:174\u201381.","journal-title":"Lung Cancer"},{"key":"1689_CR16","unstructured":"DCCPS, National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) program research data (1975\u20132017). Available from: https:\/\/seer.cancer.gov\/."},{"issue":"5","key":"1689_CR17","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1097\/COC.0000000000000305","volume":"41","author":"S Yadav","year":"2018","unstructured":"Yadav S, Sharma P, Zakalik D. Comparison of demographics, tumor characteristics, and survival between pancreatic adenocarcinomas and pancreatic neuroendocrine tumors: a population-based study. Am J Clin Oncol. 2018;41(5):485\u201391.","journal-title":"Am J Clin Oncol"},{"issue":"1","key":"1689_CR18","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3748\/wjg.v21.i1.269","volume":"21","author":"SP Yun","year":"2015","unstructured":"Yun SP, Shin N, Seo HI. Clinical outcomes of small cell neuroendocrine carcinoma and adenocarcinoma of the gallbladder. World J Gastroenterol. 2015;21(1):269\u201375.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"1689_CR19","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.ecl.2018.04.006","volume":"47","author":"DL Chan","year":"2018","unstructured":"Chan DL, Singh S. Current chemotherapy use in neuroendocrine tumors. Endocrinol Metab Clin North Am. 2018;47(3):603\u201314.","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"9","key":"1689_CR20","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1158\/2159-8290.CD-17-0245","volume":"7","author":"JW Valle","year":"2017","unstructured":"Valle JW, et al. New horizons for precision medicine in biliary tract cancers. Cancer Discov. 2017;7(9):943\u201362.","journal-title":"Cancer Discov"},{"issue":"7","key":"1689_CR21","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.14180","volume":"4","author":"J Lin","year":"2021","unstructured":"Lin J, et al. Comparison of survival and patterns of recurrence in gastric neuroendocrine carcinoma, mixed adenoneuroendocrine carcinoma, and adenocarcinoma. JAMA Netw Open. 2021;4(7): e2114180.","journal-title":"JAMA Netw Open"},{"key":"1689_CR22","doi-asserted-by":"crossref","first-page":"153303382110553","DOI":"10.1177\/15330338211055340","volume":"20","author":"B Xu","year":"2021","unstructured":"Xu B, et al. The clinicopathological features and overall survival of patients with gastric neuroendocrine carcinoma. Technol Cancer Res Treat. 2021;20:15330338211055340.","journal-title":"Technol Cancer Res Treat"},{"issue":"12","key":"1689_CR23","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1001\/jama.2018.11815","volume":"320","author":"I Baiu","year":"2018","unstructured":"Baiu I, Visser B. Gallbladder cancer. JAMA. 2018;320(12):1294.","journal-title":"JAMA"},{"issue":"2","key":"1689_CR24","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.path.2018.02.005","volume":"11","author":"AM Krasinskas","year":"2018","unstructured":"Krasinskas AM. Cholangiocarcinoma. Surg Pathol Clin. 2018;11(2):403\u201329.","journal-title":"Surg Pathol Clin"},{"issue":"10","key":"1689_CR25","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1007\/s40618-021-01528-1","volume":"44","author":"RE Rossi","year":"2021","unstructured":"Rossi RE, et al. Risk of preoperative understaging of duodenal neuroendocrine neoplasms: a plea for caution in the treatment strategy. J Endocrinol Investig. 2021;44(10):2227\u201334.","journal-title":"J Endocrinol Investig"},{"key":"1689_CR26","doi-asserted-by":"publisher","first-page":"175628482110364","DOI":"10.1177\/17562848211036453","volume":"14","author":"W Cai","year":"2021","unstructured":"Cai W, et al. Primary tumor location (right versus left side of the colon) and resection affect the survival of patients with liver metastases from colonic neuroendocrine carcinoma: a population-based study. Therap Adv Gastroenterol. 2021;14:17562848211036452.","journal-title":"Therap Adv Gastroenterol"},{"issue":"9","key":"1689_CR27","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.24750","volume":"4","author":"Z Xu","year":"2021","unstructured":"Xu Z, et al. Epidemiologic trends of and factors associated with overall survival for patients with gastroenteropancreatic neuroendocrine tumors in the United States. JAMA Netw Open. 2021;4(9): e2124750.","journal-title":"JAMA Netw Open"},{"issue":"9","key":"1689_CR28","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1007\/s10620-018-5103-7","volume":"63","author":"W Zhang","year":"2018","unstructured":"Zhang W, Hong HJ, Chen YL. Establishment of a gallbladder cancer-specific survival model to predict prognosis in non-metastatic gallbladder cancer patients after surgical resection. Dig Dis Sci. 2018;63(9):2251\u20138.","journal-title":"Dig Dis Sci"},{"issue":"43","key":"1689_CR29","doi-asserted-by":"publisher","first-page":"12211","DOI":"10.3748\/wjg.v21.i43.12211","volume":"21","author":"TO Goetze","year":"2015","unstructured":"Goetze TO. Gallbladder carcinoma: prognostic factors and therapeutic options. World J Gastroenterol. 2015;21(43):12211\u20137.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"1689_CR30","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00423-016-1491-3","volume":"402","author":"H Kurahara","year":"2017","unstructured":"Kurahara H, et al. Relationship between the surgical margin status, prognosis, and recurrence in extrahepatic bile duct cancer patients. Langenbecks Arch Surg. 2017;402(1):87\u201393.","journal-title":"Langenbecks Arch Surg"}],"container-title":["BMC Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12893-022-01689-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12893-022-01689-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12893-022-01689-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T13:08:57Z","timestamp":1656508137000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcsurg.biomedcentral.com\/articles\/10.1186\/s12893-022-01689-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,29]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1689"],"URL":"https:\/\/doi.org\/10.1186\/s12893-022-01689-7","relation":{},"ISSN":["1471-2482"],"issn-type":[{"value":"1471-2482","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,29]]},"assertion":[{"value":"20 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We promise that our research was performed in accordance with the Declaration of Helsinki and all methods were carried out in accordance with relevant guidelines and regulations in the declaration. The human data involved in this article is publicly available in the SEER database ().","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"253"}}